The Patient Engagement Collaborative (PEC) brings together 16 diverse representatives from the patient community to meet with the FDA several times a year and discuss how to achieve more meaningful patient engagement in medical product development and other regulatory discussions. The PEC, launched in December 2017, is a joint effort of CTTI and the FDA. Click here to review the PEC Framework.
Current members of the PEC include: